Lawrence Livermore and its partners are using microbes to convert carbon dioxide directly to renewable natural gas.

Livermore scientists are collecting, archiving, and documenting climate data sets to support coordinated climate modeling activities.

The Food and Drug Administration has approved the use of a medical device in humans partly developed at Livermore.

Lawrence Livermore chemist Dawn Shaughnessy, whose team helped discover six new elements on the periodic table, has been elected a fellow of the American Chemical Society.

For the first time, scientists from Lawrence Livermore and five other organizations have shown that human influences significantly impact the size of the seasonal cycle of temperature in the lowest layer of the atmosphere.

Nearly four decades of global temperature data collected by satellites reveal the atmospheric fingerprint of climate change.

Retired physicist Bruce Cohen has been selected as the recipient of the 2018 IEEE Nuclear and Plasma Sciences Society’s Charles K. Birdsall Award .

A new study compares drug responses in the brains of rodents to drug responses of brain cells cultured in Livermore-developed “brain-on-a-chip” devices

Livermore participates in an effort to observe extremely rare neutrinoless double-beta decay.

Lawrence Livermore magnetic fusion physicist Max Fenstermacher has been awarded the 2018 John Dawson Award for Excellence in Plasma Physics Research from the American Physical Society.